Dalal Anupam's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Aug 30, 2021
- Accession no.
- 0000899243-21-034546
- Filed
- Aug 30, 2021
- Trade date
- Aug 26-27, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $20.0M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000899243-21-034635 (Aug 31, 2021). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dalal AnupamCIK 0001602474 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2021 | Common Stock | PPurchaseAcquired | +1,529,402 | $13.08 | +$20,004,578.16 | 1,529,402 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 | Common Stock | AGrant or awardAcquired | +17,549 | $0.00 | $0 | 17,549 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.